Sign In
Buy ICCM
$3.54
-0.110 (-3.01%)
At Close: Jul 13, 2026
IceCure Medical to Report Q1 2022 Results and Conduct Conference Call May 18, 2022
02:09pm, Wednesday, 11'th May 2022
CAESAREA, Israel , May 11, 2022 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® S
